Left ventricular assist devices-current state and perspectives.
Mechanical circulatory support devices have become an important treatment tool for severe acute and chronic heart failure, since heart transplantation cannot meet the demands because of a lack of available donor organs. Since implantation of the first ventricular assist device a constant development of the suitability of these devices has been made. This review will introduce different generations of left ventricular assist devices (LVAD) and elaborate on clinical indications, risk stratification and current literature.
Department of Cardiovascular Surgery, Deutsches Herzzentrum München, Technische Universität München (TUM), Munich, Germany ;
Anatol
A
Prinzing
Department of Cardiovascular Surgery, Deutsches Herzzentrum München, Technische Universität München (TUM), Munich, Germany ;
Ulf
U
Herold
I. Medizinische Klinik der Technischen Universität München, Munich, Germany ;
Anna
A
Berkefeld
Department of Cardiovascular Surgery, Deutsches Herzzentrum München, Technische Universität München (TUM), Munich, Germany; ; DZHK (German Center for Cardiovascular Research) - partner site Munich HeartAlliance, Munich, Germany.
Markus
M
Krane
Department of Cardiovascular Surgery, Deutsches Herzzentrum München, Technische Universität München (TUM), Munich, Germany; ; DZHK (German Center for Cardiovascular Research) - partner site Munich HeartAlliance, Munich, Germany.
Rüdiger
R
Lange
Department of Cardiovascular Surgery, Deutsches Herzzentrum München, Technische Universität München (TUM), Munich, Germany ;
Bernhard
B
Voss
Left ventricular assist devices (LVAD); cost-effectiveness; end-stage heart failure